Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4649)
All Articles published online
|
Publishing Process of This Article
|
Aug 16, 2021 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nishimura T, Okano T, Naito M, Tsuji C, Iwanaka S, Sakakura Y, Yasuma T, Fujimoto H, D'Alessandro-Gabazza CN, Oomoto Y, Kobayashi T, Gabazza EC, Ibata H. Complete withdrawal of glucocorticoids after dupilumab therapy in allergic bronchopulmonary aspergillosis: A case report. World J Clin Cases 2021; 9(23): 6922-6928 [PMID: 34447843 DOI: 10.12998/wjcc.v9.i23.6922] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i23/6922.htm |
| Number | Citing Articles |
| 1 |
Jenny Huang, Andrew A. White. Biologics in Aspirin-Exacerbated Respiratory Disease and Allergic Bronchopulmonary Aspergillosis. Immunology and Allergy Clinics of North America 2024; 44(4): 673 doi: 10.1016/j.iac.2024.07.006
|
| 2 |
Katsuyoshi Tomomatsu, Hirotaka Yasuba, Takashi Ishiguro, Shiro Imokawa, Johsuke Hara, Seiko Soeda, Norihiro Harada, Naomi Tsurikisawa, Naohiro Oda, Shigeki Katoh, Takanori Numata, Yasuteru Sugino, Mitsuhiro Yamada, Mitsuhiro Kamimura, Takeshi Terashima, Naoki Okada, Jun Tanaka, Tsuyoshi Oguma, Koichiro Asano. Real-world efficacy of anti-IL-5 treatment in patients with allergic bronchopulmonary aspergillosis. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-32246-8
|
| 3 |
Sara Manti, Alessandro Giallongo, Giuseppe Fabio Parisi, Maria Papale, Enza Mulè, Donatella Aloisio, Novella Rotolo, Salvatore Leonardi. Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review. European Respiratory Review 2022; 31(165): 220011 doi: 10.1183/16000617.0011-2022
|
| 4 |
Tsuguhisa Nakayama, Jun Miyata, Natsuki Inoue, Shigeharu Ueki. Allergic fungal rhinosinusitis: What we can learn from allergic bronchopulmonary mycosis. Allergology International 2023; 72(4): 521 doi: 10.1016/j.alit.2023.06.005
|
| 5 |
Solange Oliveira Rodrigues Valle, Augusto Sarquis Serpa, Faradiba Sarquis Serpa. Aspergillus and Aspergillosis - Advances in Genomics, Drug Development, Diagnosis and Treatment. Infectious Diseases 2023; 25 doi: 10.5772/intechopen.112166
|
| 6 |
Hye-Jin Park, Sung-Dong Kim, Eun-Jung Cho, Kyu-Sup Cho. A Case of Concomitant Occurrence of Eosinophilic Mucin
Rhinosinusitis and Allergic Bronchopulmonary Aspergillosis Managed with
Dupilumab after Endoscopic Sinus Surgery. Journal of Clinical Otolaryngology Head and Neck
Surgery 2023; 34(4): 205 doi: 10.35420/jcohns.2023.34.4.205
|
| 7 |
Yasutaka Kawasaki, Kazuaki Nishiki, Takeshi Ishizaki. Successful treatment with dupilumab in mepolizumab-resistant allergic bronchopulmonary aspergillosis. Respiratory Medicine Case Reports 2024; 47: 101964 doi: 10.1016/j.rmcr.2023.101964
|
| 8 |
Toshiyuki Sumi, Keito Suzuki, Yuta Koshino, Takumi Ikeda, Yuichi Yamada, Hirofumi Chiba. Successful Treatment of Mucus Plug Due to Allergic Bronchopulmonary Aspergillosis Using Dupilumab. Cureus 2024; doi: 10.7759/cureus.55884
|
| 9 |
Koichiro Asano, Tsuyoshi Oguma. Allergic Bronchopulmonary Aspergillosis/Mycosis: An Allergic Disease or an Eosinophilic Disease?. Internal Medicine 2024; doi: 10.2169/internalmedicine.4386-24
|
| 10 |
Ryuta Onozato, Jun Miyata, Takanori Asakura, Ho Namkoong, Koichiro Asano, Naoki Hasegawa, Koichi Fukunaga. Development of allergic bronchopulmonary aspergillosis in a patient with nontuberculous mycobacterial‐pulmonary disease successfully treated with dupilumab: A case report and literature review. Respirology Case Reports 2024; 12(7) doi: 10.1002/rcr2.1432
|
| 11 |
Richard B. Moss. Severe Fungal Asthma: A Role for Biologics and Inhaled Antifungals. Journal of Fungi 2023; 9(1): 85 doi: 10.3390/jof9010085
|
| 12 |
Xiaoying Chen, Haopeng Zhi, Xiaohu Wang, Zicong Zhou, Huiting Luo, Jing Li, Roma Sehmi, Paul M. O’Byrne, Ruchong Chen. Efficacy of Biologics in Patients with Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis. Lung 2024; 202(4): 367 doi: 10.1007/s00408-024-00717-y
|
| 13 |
Yoshiro Kai, Masanori Yoshikawa, Masayuki Matsuda, Kentaro Suzuki, Masato Takano, Kazuya Tanimura, Nobuhiro Fujioka, Yukio Fujita, Shigeo Muro. Successful management of recurrent allergic bronchopulmonary aspergillosis after changing from mepolizumab to dupilumab: A case report. Respiratory Medicine Case Reports 2022; 39: 101723 doi: 10.1016/j.rmcr.2022.101723
|